Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/Ardelyx, Inc.
Company profile

Ardelyx, Inc.

NASDAQ: ARDX · Healthcare · Biotechnology
PublicHQ Waltham, MA · MiddlesexCIK 0001437402Reports USD
#225 of 1,394 Healthcare companies by revenue69th-percentile growth
EA Score
68B
FH 56DQ 86GM 63SS 73
v0.1 · 65/100 weight · provisional
↑ filing timeliness, 3-yr revenue growth · ↓ Piotroski F, growth stability
Methodology →
Revenue TTM
$427.7M
Rev growth YoY (TTM)
+18.2%
Net income (FY)
-$61.6M
Employees
395
Market cap
$1.3B
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$407.3M$407.3M2025
Net income-$61.6M-$61.6M2025
Operating income-$41.0M-$41.0M2025
Total assets$501.6M$501.6M2025
Liabilities$334.7M$334.7M2025
Equity$166.9M$166.9M2025

Revenue trend

FY2020 – FY2025 · USD
$1.8M
FY20
$2.7M
FY20
$7.6M
FY20
$10.1M
FY21
$52.2M
FY22
$124.5M
FY23
$333.6M
FY24
$407.3M
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product57%
Product, IBSRELA42%
License1%
By geography
UNITED STATES93%
Asia Pacific7%
North America0%
The read

Ardelyx, Inc. booked $407.3M in FY2025 revenue, growing 22% year over year — faster than most Healthcare companies we track, at a -15.1% net margin.

Peers · Healthcare
Enovis Corporation66BIRadimed Corporation86AMeiraGTx Holdings plc49DAvalyn Pharma Inc. Common Stock——
Neighbors
Middlesex →
GE Vernova Inc.$38.1B63CThermo Fisher Scientific Inc.$44.6B86AAnalog Devices, Inc.$11.0B87AThe TJX Companies, Inc.$60.4B85ABoston Scientific Corporation$20.1B88AAlnylam Pharmaceuticals, Inc.$3.7B79B+
Key facts
CEOMichael G. Raab
SectorHealthcare
IndustryBiotechnology
HeadquartersWaltham, MA
ExchangeNASDAQ: ARDX
Employees395
IPO date2014-06-19
Latest filings
8-K2026-07-028-K2026-06-1710-Q2026-04-308-K2026-04-30DEF 14A2026-04-298-K2026-02-1910-K2026-02-198-K2026-01-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies